BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

262 related articles for article (PubMed ID: 20397071)

  • 1. Varicella-zoster virus T cell tropism and the pathogenesis of skin infection.
    Arvin AM; Moffat JF; Sommer M; Oliver S; Che X; Vleck S; Zerboni L; Ku CC
    Curr Top Microbiol Immunol; 2010; 342():189-209. PubMed ID: 20397071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigations of the pathogenesis of Varicella zoster virus infection in the SCIDhu mouse model.
    Arvin AM
    Herpes; 2006 Nov; 13(3):75-80. PubMed ID: 17147912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse.
    Moffat JF; Zerboni L; Kinchington PR; Grose C; Kaneshima H; Arvin AM
    J Virol; 1998 Feb; 72(2):965-74. PubMed ID: 9444989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dissecting the Molecular Mechanisms of the Tropism of Varicella-Zoster Virus for Human T Cells.
    Sen N; Arvin AM
    J Virol; 2016 Jan; 90(7):3284-7. PubMed ID: 26792747
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Novel Human Skin Tissue Model To Study Varicella-Zoster Virus and Human Cytomegalovirus.
    Lloyd MG; Smith NA; Tighe M; Travis KL; Liu D; Upadhyaya PK; Kinchington PR; Chan GC; Moffat JF
    J Virol; 2020 Oct; 94(22):. PubMed ID: 32878893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuronal Subtype and Satellite Cell Tropism Are Determinants of Varicella-Zoster Virus Virulence in Human Dorsal Root Ganglia Xenografts In Vivo.
    Zerboni L; Arvin A
    PLoS Pathog; 2015 Jun; 11(6):e1004989. PubMed ID: 26090802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The immediate-early 63 protein of Varicella-Zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo.
    Baiker A; Bagowski C; Ito H; Sommer M; Zerboni L; Fabel K; Hay J; Ruyechan W; Arvin AM
    J Virol; 2004 Feb; 78(3):1181-94. PubMed ID: 14722273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular mechanisms of varicella zoster virus pathogenesis.
    Zerboni L; Sen N; Oliver SL; Arvin AM
    Nat Rev Microbiol; 2014 Mar; 12(3):197-210. PubMed ID: 24509782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular studies of the Oka varicella vaccine.
    Quinlivan M; Breuer J; Schmid DS
    Expert Rev Vaccines; 2011 Sep; 10(9):1321-36. PubMed ID: 21919621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicella-zoster virus neurotropism in SCID mouse-human dorsal root ganglia xenografts.
    Zerboni L; Reichelt M; Arvin A
    Curr Top Microbiol Immunol; 2010; 342():255-76. PubMed ID: 20225014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Varicella-Zoster Virus Activates CREB, and Inhibition of the pCREB-p300/CBP Interaction Inhibits Viral Replication In Vitro and Skin Pathogenesis In Vivo.
    François S; Sen N; Mitton B; Xiao X; Sakamoto KM; Arvin A
    J Virol; 2016 Oct; 90(19):8686-97. PubMed ID: 27440893
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of varicella-zoster virus neurotropism and neurovirulence using SCID mouse-human DRG xenografts.
    Zerboni L; Arvin A
    J Neurovirol; 2011 Dec; 17(6):570-7. PubMed ID: 22161683
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune evasion as a pathogenic mechanism of varicella zoster virus.
    Abendroth A; Arvin AM
    Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Granzyme B Cleaves Multiple Herpes Simplex Virus 1 and Varicella-Zoster Virus (VZV) Gene Products, and VZV ORF4 Inhibits Natural Killer Cell Cytotoxicity.
    Gerada C; Steain M; Campbell TM; McSharry B; Slobedman B; Abendroth A
    J Virol; 2019 Nov; 93(22):. PubMed ID: 31462576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VZV T cell-mediated immunity.
    Weinberg A; Levin MJ
    Curr Top Microbiol Immunol; 2010; 342():341-57. PubMed ID: 20473790
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VZV infection of keratinocytes: production of cell-free infectious virions in vivo.
    Gershon MD; Gershon AA
    Curr Top Microbiol Immunol; 2010; 342():173-88. PubMed ID: 20225011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of the repeated open reading frames, ORFs 63 and 70 and ORFs 64 and 69, of varicella-zoster virus.
    Sommer MH; Zagha E; Serrano OK; Ku CC; Zerboni L; Baiker A; Santos R; Spengler M; Lynch J; Grose C; Ruyechan W; Hay J; Arvin AM
    J Virol; 2001 Sep; 75(17):8224-39. PubMed ID: 11483768
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Varicella-zoster virus (VZV)].
    Kanai K; Yamada S; Inoue N
    Uirusu; 2010 Dec; 60(2):197-207. PubMed ID: 21488333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.
    González-Motos V; Jürgens C; Ritter B; Kropp KA; Durán V; Larsen O; Binz A; Ouwendijk WJD; Lenac Rovis T; Jonjic S; Verjans GMGM; Sodeik B; Krey T; Bauerfeind R; Schulz TF; Kaufer BB; Kalinke U; Proudfoot AEI; Rosenkilde MM; Viejo-Borbolla A
    PLoS Pathog; 2017 May; 13(5):e1006346. PubMed ID: 28542541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review: The neurobiology of varicella zoster virus infection.
    Gilden D; Mahalingam R; Nagel MA; Pugazhenthi S; Cohrs RJ
    Neuropathol Appl Neurobiol; 2011 Aug; 37(5):441-63. PubMed ID: 21342215
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.